Nick C. Fox, MD
Affiliations: | Dementia Research Centre, Institute of Neurology | University College London, London, United Kingdom |
Area:
Neuroimaging, Dementia, Clinical NeurologyWebsite:
http://www.ucl.ac.uk/neuroscience/Page.php?ID=12&ResearcherID=193Google:
"Nick Fox"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=128
http://www.ucl.ac.uk/mental-health/database/profile.php?ID=364&Submit=Submit
http://alzheimers.org.uk/site/scripts/documents_info.php?documentID=1118
Mean distance: 19.48 (cluster 51)
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Keuss SE, Coath W, Cash DM, et al. (2024) Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70. Journal of Neurology, Neurosurgery, and Psychiatry |
Llibre-Guerra JJ, Iaccarino L, Coble D, et al. (2023) Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280 |
Shirzadi Z, Schultz SA, Yau WW, et al. (2023) Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. Jama Neurology |
McKay NS, Gordon BA, Hornbeck RC, et al. (2023) Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience |
Schultz SA, Shirzadi Z, Schultz AP, et al. (2023) Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871 |
O'Connor A, Cash DM, Poole T, et al. (2023) Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [F]flortaucipir study. Alzheimer's Research & Therapy. 15: 99 |
Green RE, Lord J, Scelsi MA, et al. (2023) Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease. Alzheimer's Research & Therapy. 15: 38 |
Mead S, Fox NC. (2023) Lecanemab slows Alzheimer's disease: hope and challenges. The Lancet. Neurology. 22: 106-108 |
Vöglein J, Franzmeier N, Morris JC, et al. (2022) Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Morris JC, Weiner M, Xiong C, et al. (2022) Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology |